
EFACC Co-Director
Dr. Anagnostou is Professor of Pediatrics, in the Allergy & Immunology Division, at Baylor College of Medicine in Houston, Texas. She serves as Director of Allergy and Food Therapeutics. She is also Lead for the Adolescent Transition Program for Allergy. Dr Anagnostou is passionate about investigating new and innovative t
EFACC Co-Director
Dr. Anagnostou is Professor of Pediatrics, in the Allergy & Immunology Division, at Baylor College of Medicine in Houston, Texas. She serves as Director of Allergy and Food Therapeutics. She is also Lead for the Adolescent Transition Program for Allergy. Dr Anagnostou is passionate about investigating new and innovative therapies for food allergy. She is the PI for multiple research trials on food allergy therapy and anaphylaxis. She is also leading research projects on food allergy prevention, food-induced anaphylaxis, the microbiome and shared decision-making. Dr Anagnostou serves as the Chair of the Food Allergy Committee at the ACAAI. She has previously served as the Chair of the Adverse Reactions to Foods Committee at the AAAAI.

EFACC Co-Director
Russell Settipane, MD, co-director of the Allergy and Asthma Centers in East Providence, Rhode Island, is a Clinical Professor of Medicine at the Warren Alpert Medical School of Brown University. His allergy and immunology fellowship was completed at Scripps Clinic and Research Foundation in La Jolla, CA. He has participa
EFACC Co-Director
Russell Settipane, MD, co-director of the Allergy and Asthma Centers in East Providence, Rhode Island, is a Clinical Professor of Medicine at the Warren Alpert Medical School of Brown University. His allergy and immunology fellowship was completed at Scripps Clinic and Research Foundation in La Jolla, CA. He has participated in over 100 clinical trials and has authored more than 150 scientific articles, reviews, and book chapters in the field of allergy & immunology. Currently, he serves as President of the Rhode Island Society of Allergy, the American Association of Certified Allergists, and the Eastern Allergy Conference.

Dr. Upton is Division Head of Immunology and Allergy at The Hospital for Sick Children and Professor of Paediatrics at the University of Toronto. She serves on the Board of the Canadian Society of Allergy and Clinical Immunology and the Healthcare Advisory Board of Food Allergy Canada. She earned her MD from Western University, completed
Dr. Upton is Division Head of Immunology and Allergy at The Hospital for Sick Children and Professor of Paediatrics at the University of Toronto. She serves on the Board of the Canadian Society of Allergy and Clinical Immunology and the Healthcare Advisory Board of Food Allergy Canada. She earned her MD from Western University, completed residency at McMaster, fellowship at Toronto, and an MPH at Harvard TH Chan School of Public Health. Her clinical practice addresses immunodeficiency and allergy, with research focused on children with food and vaccine allergies and those with immunodeficiencies.

S Shahzad Mustafa is the division head of allergy, immunology, and rheumatology at Rochester Regional Health. In addition to seeing both pediatric and adult patients, Dr. Mustafa participates in clinical research, with a special interest in quality of life considerations in food allergy, and secondary immunodeficiency due to malignancy an
S Shahzad Mustafa is the division head of allergy, immunology, and rheumatology at Rochester Regional Health. In addition to seeing both pediatric and adult patients, Dr. Mustafa participates in clinical research, with a special interest in quality of life considerations in food allergy, and secondary immunodeficiency due to malignancy and chemotherapeutics. In hopes of optimizing the patient experience, Dr. Mustafa focuses on quality initiatives and improving systems of healthcare delivery.

Emeritus Fellow of both the AAAAI and ACAAI. Pediatric residency at Washington University, St. Louis. Fellowship in Allergy & Immunology at the National Jewish Hospital and Research Center, Denver, Colorado. Former Senior partner, Allergy Consultants, P.C. 40 years in private practice in St. Louis, Missouri. Current President, THE PBL Ins
Emeritus Fellow of both the AAAAI and ACAAI. Pediatric residency at Washington University, St. Louis. Fellowship in Allergy & Immunology at the National Jewish Hospital and Research Center, Denver, Colorado. Former Senior partner, Allergy Consultants, P.C. 40 years in private practice in St. Louis, Missouri. Current President, THE PBL Institute, LLC. He has facilitated hundreds of educational conferences in the A./I. field nationally, involving interactive case discussions known as “problem-based learning” or PBL. He has initiated PBL workshops into both the AAAAI and ACAAI annual meetings, the Eastern Allergy Conferences yearly for the last 21 years.

Richard L. Wasserman, MD, PhD is Medical Director of Pediatric Allergy and Immunology at Medical City Children’s Hospital and Vice President of the Food Allergy Support Team.
An honors graduate of Hobart College, he received a PhD in immunology from Mt. Sinai School of Medicine and his MD from the University of Texas Southwestern Medical
Richard L. Wasserman, MD, PhD is Medical Director of Pediatric Allergy and Immunology at Medical City Children’s Hospital and Vice President of the Food Allergy Support Team.
An honors graduate of Hobart College, he received a PhD in immunology from Mt. Sinai School of Medicine and his MD from the University of Texas Southwestern Medical School (UTSWMS). Following training in pediatrics and fellowships in bone marrow transplantation and immunology at The Children’s Hospital of Philadelphia, he served on the faculty of the University of Texas Southwestern Medical School for 33 years and directed the Immunology Clinic for 19 years. In 1988, Dr. Wasserman started a private practice in allergy/immunology and a research group that has conducted more than 130 FDA-approved studies. He has served as a member of the AAAAI Board of Directors and the Editorial Boards of JACI: In Practice, Annals of Allergy, Asthma and Immunology, Frontiers in Allergy, and the Journal of Food Allergy. He has co-authored more than 175 peer-reviewed publications, case reports, book chapters, and reviews. Dr. Wasserman has been a leader in food allergy treatment. He co-founded the Food Allergy Support Team and has moderated the annual FAST food allergy treatment conferences.

Dr. Sami Bahna is Professor Emeritus and former Chief of Allergy/Immunology at Louisiana State University- Shreveport. He published 215 papers, 40 book-chapters, and a book on "Allergies to Milk" which was translated into Italian, Russian and Japanese. He served on editorial boards of several medical journals on allergy/immunology and ped
Dr. Sami Bahna is Professor Emeritus and former Chief of Allergy/Immunology at Louisiana State University- Shreveport. He published 215 papers, 40 book-chapters, and a book on "Allergies to Milk" which was translated into Italian, Russian and Japanese. He served on editorial boards of several medical journals on allergy/immunology and pediatrics. He served on several national and international societies and was President of the American College of Allergy/Asthma/Immunology He received many national and international recognitions and prestigious awards, including Distinguished Service, International Distinguished Fellow, Humanism in Medicine, Life-time Achievement Gold-Headed Cane, and was named among the World’s Top 2% Scientists.

Director of the Clinical Research Center at Boston Children’s Hospital and the S.Jean Emans, MD, Endowed Chair & Professor of Pediatrics at Harvard Medical School, conducts innovative, NIH-funded community, school, and home-based studies focused on reducing health disparities) and directs a renowned multidisciplinary program built from sc
Director of the Clinical Research Center at Boston Children’s Hospital and the S.Jean Emans, MD, Endowed Chair & Professor of Pediatrics at Harvard Medical School, conducts innovative, NIH-funded community, school, and home-based studies focused on reducing health disparities) and directs a renowned multidisciplinary program built from scratch. She has had continuous NIH funding for 23 years. Currently, she is ranked among the top five worldwide asthma experts in the past decade, as determined by Expertscape. She has authored over 460 publications in scientific journals and is an elected member of the American Society for Clinical Investigation and the Association of American Physicians, honor research societies, and is an associate editor for JACI.
Dr. Phipatanakul is deeply committed to mentoring the next generation of investigators, providing guidance on achieving balance between work and family, supporting over 150 trainees to achieve their own independent careers and has received multiple mentoring awards from Harvard, Boston Children’s Hospital, the American Academy of Pediatrics, and the AAAAI.

Dr. Bukstein is a board-certified allergist/ immunologist and pediatric pulmonologist. He holds hospital staff appointments at St. Mary’s Hospital Medical Center, in Madison and Waukesha Memorial Hospital in Milwaukee, Wisconsin. He worked as a pediatric intensive care physician for 17 years at St. Mary’s Hospital Medical Center. He has b
Dr. Bukstein is a board-certified allergist/ immunologist and pediatric pulmonologist. He holds hospital staff appointments at St. Mary’s Hospital Medical Center, in Madison and Waukesha Memorial Hospital in Milwaukee, Wisconsin. He worked as a pediatric intensive care physician for 17 years at St. Mary’s Hospital Medical Center. He has been active in resident education and was an Assistant professor of Family Practice and pediatrics at the University of Wisconsin for over 30 years. He serves as a fellow of the American Academy of Allergy Asthma & Immunology; the American College of Allergy, Asthma & Immunology; and the American Thoracic Society. Dr. Bukstein is considered a national expert in using clinical outcomes for managed care. He has had numerous articles published in peer-reviewed journals, including The American Journal of Managed Care, Allergy, Pediatrics, and Journal of Clinical Outcomes Management. He also gives approximately 50 presentations annually at national and international meetings. These presentations have focused on allergic disease, asthma, quality of life, health outcomes and telemedicine.

Dr. Rider serves as a Professor in the Department of Health Systems & Implementation Science at the Virginia Tech Carilion School of Medicine in Roanoke Virginia. He runs CHILI, the computational human immunology lab and innovation hub, which focuses on advancing epidemiologic and predictive analyses to inform primary immune disease patie
Dr. Rider serves as a Professor in the Department of Health Systems & Implementation Science at the Virginia Tech Carilion School of Medicine in Roanoke Virginia. He runs CHILI, the computational human immunology lab and innovation hub, which focuses on advancing epidemiologic and predictive analyses to inform primary immune disease patient outcomes and biological discovery. Additionally, he is an Associate Chief Medical Information Officer focused on research data operations and a Clinical Immunologist at the Carilion Clinic. Dr. Rider is board-certified in Allergy-Immunology and Clinical Informatics.

Elissa Abrams is a Professor at the University of Manitoba and holds an adjunct appointment at UBC. She is President of the Allergy Section of the Canadian Pediatric Society, on the Board of the Canadian Society of Allergy and Clinical Immunology and is member of the Joint Task Force on Practice Parameters as well as the Global Burden of
Elissa Abrams is a Professor at the University of Manitoba and holds an adjunct appointment at UBC. She is President of the Allergy Section of the Canadian Pediatric Society, on the Board of the Canadian Society of Allergy and Clinical Immunology and is member of the Joint Task Force on Practice Parameters as well as the Global Burden of Disease Unit at the University of Washington. She has a Master of Public Health from Johns Hopkins University and is a Medical Advisor at Public Health Agency of Canada within the National Advisory Committee on Immunization. She has published over 250 articles in peer-reviewed journals and co-authored over 15 allergy practice guidelines through the CPS and CSACI.

Dr. Edmond S. Chan is a Pediatric Allergist at BC Children's Hospital in Vancouver, Canada. He is a University of British Columbia Clinical Professor and Head (Division of Allergy), leading a dedicated food allergy research program. His primary interest is food allergy, and secondary interest is eosinophilic esophagitis. He has 230 peer-r
Dr. Edmond S. Chan is a Pediatric Allergist at BC Children's Hospital in Vancouver, Canada. He is a University of British Columbia Clinical Professor and Head (Division of Allergy), leading a dedicated food allergy research program. His primary interest is food allergy, and secondary interest is eosinophilic esophagitis. He has 230 peer-reviewed publications, and has authored several national/international guidelines (e.g. co-lead of several food allergy prevention guidelines, co-lead of CSACI oral immunotherapy guidelines, co-author of AGA/AAAAI/ACAAI EoE management guidelines, and co-lead of Canadian EoE Delphi Consensus recommendations). He is President of the CSACI (Canadian Society of Allergy & Clinical Immunology).

Dr. Tam is part of the Division of Clinical Immunology and Allergy at Children’s Hospital Los Angeles; and an Associate Professor, Clinical Pediatrics at Keck School of Medicine, University of Southern California.

Dr. Roxanne C. Oriel is an Assistant Professor of Pediatrics in the Serena and John Liew Division of Pediatric Allergy and Immunology at the Icahn School of Medicine at Mount Sinai. She specializes in food allergy with a focus on emerging therapeutics. Her work is driven by a passion for improving patients’ daily lives through meaningful,
Dr. Roxanne C. Oriel is an Assistant Professor of Pediatrics in the Serena and John Liew Division of Pediatric Allergy and Immunology at the Icahn School of Medicine at Mount Sinai. She specializes in food allergy with a focus on emerging therapeutics. Her work is driven by a passion for improving patients’ daily lives through meaningful, practical gains. She is actively involved in clinical trials in EPIT, SLIT, OIT, and a novel peanut vaccine, and currently leads the AAAAI Adverse Reactions to Foods Committee’s Mild Food Allergy workgroup.

Dr. Buckey cares for pediatric and adult patients at the Children’s Hospital of Philadelphia and Hospital of the University of Pennsylvania, respectively. Dr. Buckey’s research interests include eosinophilic esophagitis, food allergy, oral immunotherapy, medical ethics, and health equity. Dr. Buckey is a pioneer in investigating the inter
Dr. Buckey cares for pediatric and adult patients at the Children’s Hospital of Philadelphia and Hospital of the University of Pennsylvania, respectively. Dr. Buckey’s research interests include eosinophilic esophagitis, food allergy, oral immunotherapy, medical ethics, and health equity. Dr. Buckey is a pioneer in investigating the intersection of medical ethics with allergy and immunology. He developed the first comprehensive ethical framework for allergy and immunology to assist clinicians with navigating ethically complex decisions in their practices. Dr. Buckey has been interviewed by the American Academy of Allergy, Asthma and Immunology on the role of medical ethics in allergy and immunology.

Matthew Greenhawt, MD, MBA, MSc, is the chief medical officer for the Asthma and Allergy Foundation of America, having most recently served as a professor in the Department of Pediatrics, Section of Allergy and Immunology at Children’s Hospital Colorado and the University of Colorado School of Medicine in Aurora, CO. Dr. Greenhawt earned
Matthew Greenhawt, MD, MBA, MSc, is the chief medical officer for the Asthma and Allergy Foundation of America, having most recently served as a professor in the Department of Pediatrics, Section of Allergy and Immunology at Children’s Hospital Colorado and the University of Colorado School of Medicine in Aurora, CO. Dr. Greenhawt earned his medical degree from Tufts University School of Medicine in Boston, MA. He then completed his residency in pediatrics at Morgan Stanley Children’s Hospital of New York-Presbyterian, Columbia Presbyterian Medical Center in New York, NY and his fellowship in allergy/immunology at the University of Michigan in Ann Arbor, MI. He also holds an MBA from Tufts University and a MSc degree in health and healthcare policy from the University of Michigan, Rackham School of Graduate Studies. Dr. Greenhawt is board certified in pediatrics and allergy/immunology.
Dr. Greenhawt’s research interests include shared decision-making, cost-effectiveness and comparative effectiveness research, outcomes and health services research, prevention and treatment, and public policy related to food allergy, anaphylaxis, and allergic diseases. He has served as an investigator on numerous industry, advocacy, and NIH-funded studies.
Dr Greenhawt has authored over 360 peer-reviewed articles, in addition to numerous abstracts and book chapters. He is the senior associate editor for the Annals of Allergy, Asthma and Immunology, and recently completed a 10-year term as a member of the Joint Taskforce of Allergy Practice Parameters. Dr. Greenhawt involved with many committees, including the Brighton Collaboration Criteria Vaccine Anaphylaxis Case Definition 2.0 work group, multiple AAAAI and EAACI committees, and is the former chair of the ACAAI Food Allergy Committee.
For review articles and abstracts from EFACC, visit the Journal of Food Allergy
EFACC • 450 Veterans Memorial Parkway, Bldg 15 • East Providence, RI 02914
© 2026 EFACC. All Rights Reserved.